In this cross-sectional study, which is one of the first to focus on subjects with preclinical AD, we found that MBI scores, but not episodic memory impairment, were independently associated with early tau pathology determined using either CSF P-tau181 or tau-PET. This evidence concerns the gene MAPT and Alzheimer disease.